Temporal changes in TFF3 expression and jejunal morphology during methotrexate-induced damage and repair

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 277, Issue 4 40-4, 1999, Pages

  Xian, C J ^a   Howarth, G S ^a   Mardell, C E ^a   Cool, J C ^a   Familari, M ^b   Read, L C ^a   Giraud, A S ^b  

^a CHILD HEALTH RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Intestinal mucosal injury; Intestinal trefoil peptide; Mucositis; Regeneration

Indexed keywords

INTESTINAL TREFOIL FACTOR; METHOTREXATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CELL REGENERATION; GOBLET CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

EID: 0032719523     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.1999.277.4.g785     Document Type: Article

References (39)

1. Alison, M. R., R. Chinery, R. Poulsom, P. Ashwood, J. M. Longcroft, and N. A. Wright. Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor α mRNAs in rat stomach. J. Pathol. 175: 405-414, 1995.
2. Allen, A., A. Bell, M. Mantle, and J. P. Pearson. The structure and physiology of gastrointestinal mucus. Adv. Exp. Med. Biol. 144: 115-133, 1982.
3. Altmann, G. G. Changes in the mucosa of the small intestine following methotrexate administration or abdominal X-irradiation. Am. J. Anat. 140: 263-280, 1974.
4. Babyatsky, M., M. DeBeaumont, L. Thim, and D. K. Podolsky. Oral trefoil peptides protect against ethanol-and indomethacin-induced gastric injury in rats. Gastroenterology 110: 489-497, 1996.
5. Bancroft, J. D., and H. C. Cook. Manual of Histological Techniques and Their Diagnostic Application. Singapore: Churchill Livingstone, 1994, p. 131-172.
6. Chinery, R., and R. Playford. Combined intestinal trefoil factor and epidermal growth factor is prophylactic against indomethacin-induced gastric damage in the rat. Clin. Sci. (Colch.) 88: 401-403, 1995.
7. Chinery, R., R. Poulsom, L. A. Rogers, R. E. Jeffery, J. M. Longcroft, A. M. Hanby, and N. A. Wright. Localization of intestinal trefoil-factor mRNA in rat stomach and intestine by hybridization in situ. Biochem. J. 285: 5-8, 1992.
8. Cook, G. A., L. Thim, N. D. Yeomans, and A. S. Giraud. Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in rats. J. Gastroenterol. Hepatol. 13: 363-370, 1998.
9. Cook, G. A., N. D. Yeomans, and A. S. Giraud. Temporal expression of trefoil peptides in the TGF-α knockout mouse after gastric ulceration. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G1540-G1549, 1997.
10. Dignass, A., K. Lynch-Devaney, H. Kindon, L. Thim, and D. Podolsky. Trefoil peptides promote epithelial migration through a transforming growth factor-β independent pathway. J. Clin. Invest. 94: 376-383, 1994.
11. Familari, M., G. A. Cook, D. R. Taupin, G. Marryatt, N. D. Yeomans, and A. S. Giraud. Trefoil peptides are early markers of gastrointestinal maturation in the rat. Int. J. Dev. Biol. 42: 783-789, 1998.
12. Horgensen, K. H., L. Thim, and H. E. Jacobsen. Pancreatic spasmolytic polypeptide (PSP). I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul. Pept. 3: 221-230, 1982.
13. Howarth, G. S., G. L. Francis, J. C. Cool, X. Xu, R. W. Byard, and L. C. Read. Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J. Nutr. 126: 2519-2530, 1996.
14. Itoh, H., M. Tomita, H. Uchino, T. Kobayashi, H. Kataoka, R. Sekiya, and Y. Nawa. cDNA cloning of rat pS2 peptide and expression of trefoil peptides in acetic acid-induced colitis. Biochem. J. 318: 939-944, 1996.
15. Jeffrey, G. P., P. S. Oates, T. C. Wang, M. W. Babyatsky, and S. J. Brand. Spasmolytic polypeptide: a trefoil peptide secreted by rat gastric mucous cells. Gastroenterology 106: 336-345, 1993.
16. Kindon, H., C. Pothoulakis, L. Thim, K. Lynch-Devaney, and D. K. Podolsky. Trefoil peptide protection of intestinal epithelial barrier function: cooperative interaction with mucin glycoprotein. Gastroenterology 109: 516-523, 1995.
17. Krieg, P.A., and D.A. Melton. In vitro synthesis with SP6 RNA polymerase. Methods Enzymol. 155: 397-415, 1988.
18. Lefebvre, O., M.-P. Chenard, R. Masson, J. Linares, A. Dierich, M. LeMeur, C. Wendung, C. Tomasetto, P. Chambon, and M.-C. Rio. Gastric mucosa abnormalities and tumorigenesis in mice lacking the pS2 trefoil protein. Science 274: 259-262, 1996.
19. Mashimo, H., D.-C. Wu, D. K. Podolsky, and M. C. Fishman. Impaired defence of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265, 1996.
20. Playford, R. J., T. Marchband, R. Chinery, R. Evison, M. Pignatelli, R. A. Boulton, L. Thim, and A. M. Hanby. Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 108: 108-116, 1995.
21. Playford, R. J., T. Marchbank, R. A. Goodlad, R. A. Chinery, R. Poulsom, and A. M. Hanby. Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc. Natl. Acad. Sci. USA 93: 2137-2142, 1996.
22. Podolsky, D. K., K. Lynch-Devaney, J. L. Stow, P. Oates, B. Murgue, M. DeBeaumont, B. E. Sands, and Y. R. Mahida. Identification of human intestinal trefoil factor: goblet cell-specific expression of a peptide target for apical secretion. J. Biol. Chem. 268: 6694-6702, 1993. [Corrigenda. J. Biol. Chem. 268, June 1993, p. 12230.]
23. Poulsom, R. Trefoil peptides. Baillieres Clin. Gastroenterol. 10: 113-134, 1996.
24. Poulsom, R. Molecular aspects of restitution. In: The Gut as a Model in Cell and Molecular Biology, edited by F. Halter, D. Winton, and N. A. Wright. Lancaster, PA: Kluwer Academic, 1997, p. 204-216.
25. Poulsom, R., D. E. Begos, and I. M. Modlin. Molecular aspects of restitution: functions of trefoil peptides. Yale J. Biol. Med. 69: 137-146, 1996.
26. Poulsom, R., R. Chinery, C. Sarraf, S. Van Noorden, G. W. H. Stamp, E.-N. Lalani, G. Elia, and N. A. Wright. Trefoil peptide gene expression in small intestinal Crohn's disease and dietary adaptation. J. Clin. Gastroenterol. 17: S78-S91, 1993.
27. Poulsom, R., and N. A. Wright. Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am. J. Physiol. 265 (Gastrointest. Liver Physiol. 28): G205-G213, 1993.
28. Ribieras, S., C. Tomasetto, and M. C. Rio. The pS2/TFF1 trefoil factor, from basic research to clinical applications. Biochim. Biophys. Acta 1378: F61-F77, 1998.
29. Sands, B. E., and D. K. Podolsky. The trefoil peptide family. Annu. Rev. Physiol. 58: 253-273, 1996.
30. Suemori, S., K. Lynch-Devaney, and D. K. Podolsky. Identification and characterization of rat intestinal trefoil factor: tissue-and cell-specific member of the trefoil protein family. Proc. Natl. Acad. Sci. USA 88: 11017-11021, 1991.
31. Taminiau, J. A., D. G. Gall, and J. R. Hamilton. Response of the rat small intestine epithelium to methotrexate. Gut 21: 486-492, 1980.
32. Taupin, D. R., K. C. Pang, S. P. Green, and A. S. Giraud. The trefoil peptides spasmolytic polypeptide and intestinal trefoil factor are major secretory products of the rat gut. Peptides 16: 1001-1005, 1995.
33. Thim, L. Trefoil peptides: a new family of gastrointestinal molecules. Digestion 55: 353-360, 1994.
34. Thim, L. Trefoil peptides: from structure to function. Cell. Mol. Life Sci. 53: 888-903, 1997.
35. Thim, L., H. F. Woldike, P. F. Nielsen, M. Christensen, K. Devaney, and D. K. Podolsky. Characterization of human and rat intestinal trefoil factor (ITF) produced in yeast. Biochemistry 34: 4757-4763, 1995.
36. Tomita, M., H. Itoh, N. Ishikawa, A. Higa, H. Ide, Y. Murakumo, H. Maruyama, Y. Koga, and Y. Nawa. Molecular cloning of mouse intestinal trefoil factor and its expression during goblet cell changes. Biochem. J. 311: 293-297, 1995.
37. Tran, C. P., G. A. Cook, G. Marryatt, L. M. Parker, L. Thim, N. O. Yeomans, and A. S. Giraud. The trefoil peptide TFF2 potently accelerates healing in a rat model of inflammatory bowel disease (Abstract). Gastroenterology 114: A110, 1998.
38. Trier, J. S. Morphologic alterations induced by methotrexate in the mucosa of human proximal intestine. Gastroenterology 42: 295-305, 1962.
39. Wright, N. A., R. Poulsom, G. W. Stamp, P. A. Hall, R. E. Jeffery, J. M. Longcroft, M. C. Rio, C. Tomasetto, and P. Chambon. Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J. Pathol. 162: 279-284, 1990.